Overview Dividends

(MCHX) Marchex - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US56624R1086

Marketing, Analytics, Messaging, AI, Insights

MCHX EPS (Earnings per Share)

EPS Growth (3Y CAGR): 29.92%
EPS Trend (3Y Correlation): 61.3%

MCHX Revenue

Revenue Growth (3Y CAGR): -4.42%
Revenue Trend (3Y Correlation): -72.6%

Description: MCHX Marchex

Marchex Inc. (NASDAQ:MCHX) is a conversation intelligence company that leverages AI-powered solutions to provide conversational analytics and related services to businesses in the United States, Canada, and internationally. The companys product suite includes Marketing Edge, Sonar Business Text Messaging, Marchex Platform Services, Spotlight, Engage, Call Summary, and Sentiment Suite, all designed to help businesses optimize their marketing efforts, improve customer engagement, and drive sales.

By utilizing Marchexs conversation intelligence products, businesses can gain actionable insights from customer interactions, identify high-value leads, and enhance their overall performance. The companys AI-driven solutions enable businesses to close the sales loop, segment audiences, and improve automated bidding. With a strong focus on innovation, Marchex has established itself as a leader in the conversation intelligence space.

Analyzing the , we can observe that the stocks current price is $1.72, with a 20-day SMA of $1.48 and a 50-day SMA of $1.58, indicating a potential bullish trend. The 200-day SMA is $1.82, suggesting that the stock may be facing resistance at this level. The ATR of 0.13 (7.31%) indicates moderate volatility.

Considering the , Marchexs market capitalization stands at $71.12M USD, with a negative P/E ratio and a Return on Equity (RoE) of -16.52%. This suggests that the company is currently unprofitable. However, the lack of a P/E ratio may indicate that the company is reinvesting its earnings in growth initiatives.

Based on the and , our forecast suggests that Marchex Inc.s stock price may experience a short-term bullish trend, potentially driven by the companys innovative products and growing demand for conversation intelligence solutions. However, the negative RoE and lack of profitability may continue to weigh on the stocks long-term performance. We forecast a potential price target of $2.00 in the short term, but caution that the stocks volatility and fundamental challenges may impact its overall performance.

To mitigate potential risks, investors may consider monitoring Marchexs future earnings reports, product developments, and industry trends to gauge the companys progress in achieving profitability and driving growth.

MCHX Stock Overview

Market Cap in USD	87m
Sub-Industry	Advertising
IPO / Inception	2004-03-31

MCHX Stock Ratings

Growth Rating	-3.01%
Fundamental	29.6%
Dividend Rating	7.57%
Return 12m vs S&P 500	-15.8%
Analyst Rating	5.0 of 5

MCHX Dividends

Currently no dividends paid

MCHX Growth Ratios

Growth Correlation 3m	2.9%
Growth Correlation 12m	21.9%
Growth Correlation 5y	-56.9%
CAGR 5y	1.84%
CAGR/Max DD 5y	0.03
Sharpe Ratio 12m	-0.91
Alpha	-19.36
Beta	1.186
Volatility	64.17%
Current Volume	7.1k
Average Volume 20d	18k
Stop Loss	1.8 (-8.2%)
Signal	0.19

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (-4.64m TTM) > 0 and > 6% of Revenue (6% = 2.85m TTM)

FCFTA -0.04 (>2.0%) and ΔFCFTA 9.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 26.01% (prev 26.60%; Δ -0.59pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.01 (>3.0%) and CFO -562.0k > Net Income -4.64m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 2.42 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (48.6m) change vs 12m ago 12.77% (target <= -2.0% for YES)

Gross Margin 64.54% (prev 60.79%; Δ 3.75pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 108.7% (prev 107.6%; Δ 1.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -6.52 (EBITDA TTM -1.84m / Interest Expense TTM 640.0k) >= 6 (WARN >= 3)

Altman Z'' -58.79

(A) 0.29 = (Total Current Assets 21.1m - Total Current Liabilities 8.73m) / Total Assets 42.0m

(B) -7.81 = Retained Earnings (Balance) -328.1m / Total Assets 42.0m

warn (B) unusual magnitude: -7.81 — check mapping/units

(D) -32.96 = Book Value of Equity -327.6m / Total Liabilities 9.94m

Total Rating: -58.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 29.60

1. Piotroski 2.0pt = -3.0

2. FCF Yield -1.96% = -0.98

3. FCF Margin -3.23% = -1.21

4. Debt/Equity 0.05 = 2.50

5. Debt/Ebitda -0.84 = -2.50

6. ROIC - WACC -23.70% = -12.50

7. RoE -14.25% = -2.38

8. Rev. Trend -72.56% = -3.63

9. Rev. CAGR -4.42% = -0.74

10. EPS Trend 61.25% = 1.53

11. EPS CAGR 29.92% = 2.50

What is the price of MCHX shares?

As of September 01, 2025, the stock is trading at USD 1.96 with a total of 7,102 shares traded.
Over the past week, the price has changed by -0.51%, over one month by +2.08%, over three months by +21.74% and over the past year by -1.46%.

Is Marchex a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Marchex (NASDAQ:MCHX) is currently (September 2025) a stock to sell. It has a ValueRay Fundamental Rating of 29.60 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MCHX is around 1.71 USD . This means that MCHX is currently overvalued and has a potential downside of -12.76%.

Is MCHX a buy, sell or hold?

Marchex has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy MCHX.

Strong Buy: 1
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the MCHX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	4	104.1%
Analysts Target Price	4	104.1%
ValueRay Target Price	1.9	-1%

Last update: 2025-08-26 02:47

MCHX Fundamental Data Overview

Market Cap USD = 87.0m (87.0m USD * 1.0 USD.USD)
CCE Cash And Equivalents = 10.5m USD (Cash And Short Term Investments, last quarter)
P/S = 1.831
P/B = 2.7161
P/EG = -4.2
Beta = 1.923
Revenue TTM = 47.5m USD
EBIT TTM = -4.17m USD
EBITDA TTM = -1.84m USD
Long Term Debt = 1.21m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 330.0k USD (from shortTermDebt, last quarter)
Debt = 1.54m USD (Calculated: Short Term 330.0k + Long Term 1.21m)
Net Debt = -9.61m USD (from netDebt column, last quarter)
Enterprise Value = 78.1m USD (87.0m + Debt 1.54m - CCE 10.5m)
Interest Coverage Ratio = -6.52 (Ebit TTM -4.17m / Interest Expense TTM 640.0k)
FCF Yield = -1.96% (FCF TTM -1.53m / Enterprise Value 78.1m)
FCF Margin = -3.23% (FCF TTM -1.53m / Revenue TTM 47.5m)
Net Margin = -9.76% (Net Income TTM -4.64m / Revenue TTM 47.5m)
Gross Margin = 64.54% ((Revenue TTM 47.5m - Cost of Revenue TTM 16.9m) / Revenue TTM)
Tobins Q-Ratio = -0.24 (set to none) (Enterprise Value 78.1m / Book Value Of Equity -327.6m)
Interest Expense / Debt = 40.68% (Interest Expense 626.0k / Debt 1.54m)
Taxrate = 5.56% (from quarterly Income Tax Expense: 5000 / 90.0k)
NOPAT = -4.17m (EBIT -4.17m, no tax applied on loss)
Current Ratio = 2.42 (Total Current Assets 21.1m / Total Current Liabilities 8.73m)
Debt / Equity = 0.05 (Debt 1.54m / last Quarter total Stockholder Equity 32.0m)
Debt / EBITDA = -0.84 (Net Debt -9.61m / EBITDA -1.84m)
Debt / FCF = -1.00 (Debt 1.54m / FCF TTM -1.53m)
Total Stockholder Equity = 32.5m (last 4 quarters mean)
RoA = -11.05% (Net Income -4.64m, Total Assets 42.0m )
RoE = -14.25% (Net Income TTM -4.64m / Total Stockholder Equity 32.5m)
RoCE = -12.37% (Ebit -4.17m / (Equity 32.5m + L.T.Debt 1.21m))
RoIC = -12.83% (NOPAT -4.17m / Invested Capital 32.5m)
WACC = 10.88% (E(87.0m)/V(88.6m) * Re(10.39%)) + (D(1.54m)/V(88.6m) * Rd(40.68%) * (1-Tc(0.06)))
Shares Correlation 5-Years: -40.0 | Cagr: -0.15%
Discount Rate = 10.39% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -1.53m)
Revenue Correlation: -72.56 | Revenue CAGR: -4.42%
Rev Growth-of-Growth: -0.65
EPS Correlation: 61.25 | EPS CAGR: 29.92%
EPS Growth-of-Growth: 46.47

Additional Sources for MCHX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle